User profiles for VASILIKI RAPTI

Vasiliki Rapti

MD
Verified email at med.uoa.gr
Cited by 1757

[HTML][HTML] The “old” and the “new” antibiotics for MDR gram-negative pathogens: for whom, when, and how

I Karaiskos, S Lagou, K Pontikis, V Rapti… - Frontiers in public …, 2019 - frontiersin.org
The recent expansion of multidrug resistant and pan-drug-resistant pathogens poses
significant challenges in the treatment of healthcare associated infections. An important …

[HTML][HTML] Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

…, E Koukaki, PC Fragkou, V Panou, V Rapti… - Nature …, 2021 - nature.com
A central paradigm of immunity is that interferon (IFN)-mediated antiviral responses precede
pro-inflammatory ones, optimizing host protection and minimizing collateral damage 1 , 2 . …

[HTML][HTML] The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: …

PC Fragkou, G Poulakou, A Blizou, M Blizou, V Rapti… - Microorganisms, 2019 - mdpi.com
Treatment options for multidrug resistant Acinetobacter baumannii strains (MDR-AB) are
limited. Minocycline has been used alone or in combination in the treatment of infections …

Endothelial dysfunction in acute and long standing COVID− 19: A prospective cohort study

…, V Sakka, G Charalambous, V Rapti… - Vascular …, 2022 - Elsevier
Background Coronavirus disease-19 (COVID-19) is implicated by active endotheliitis, and
cardiovascular morbidity. The long-COVID-19 syndrome implications in atherosclerosis have …

[HTML][HTML] New insights into SARS-CoV-2 and cancer cross-talk: Does a novel oncogenesis driver emerge?

V Rapti, T Tsaganos, IA Vathiotis, NK Syrigos, P Li… - Vaccines, 2022 - mdpi.com
Since the pandemic’s onset, a growing population of individuals has recovered from SARS-CoV-2
infection and its long-term effects in some of the convalescents are gradually being …

[HTML][HTML] Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19

…, E Jahaj, K Protopapas, K Leontis, V Rapti… - PLoS …, 2020 - journals.plos.org
Introduction Greece is a country with limited spread of SARS-CoV-2 and cumulative
infection attack rate of 0.12% (95% CI 0.06–0.26). Health care workers (HCWs) are a well-…

Beneficial effects of intermediate dosage of anticoagulation treatment on the prognosis of hospitalized COVID-19 patients: the ETHRA study

…, E Dimakakos, A Kollias, KG Kyriakoulis, V Rapti… - in vivo, 2021 - iv.iiarjournals.org
Background/Aim: To investigate the efficacy (prognosis, coagulation/inflammation biomarkers)
and safety (bleeding events) of different anticoagulation dosages in COVID-19 inpatients. …

Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and …

…, K Kounouklas, ME Livanou, M Zotou, V Rapti… - Vaccine, 2023 - Elsevier
Aim We estimated vaccine effectiveness (VE) of full (booster) vaccination against severe
outcomes in hospitalized COVID-19 patients during the Delta and Omicron waves. Methods The …

[HTML][HTML] Delineating the SARS-CoV-2 induced interplay between the host immune system and the DNA damage response network

C Papanikolaou, V Rapti, D Stellas, DT Stefanou… - Vaccines, 2022 - mdpi.com
COVID-19 is an infectious disease caused by the SARS-CoV-2 coronavirus and characterized
by an extremely variable disease course, ranging from asymptomatic cases to severe …

[HTML][HTML] Greek Remdesivir Cohort (GREC) study: effectiveness of antiviral drug remdesivir in hospitalized patients with COVID-19 pneumonia

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - Microorganisms, 2022 - mdpi.com
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …